Three-Dimensional Conformal Radiotherapy of Unresectable Hepatocellular Carcinoma Patients for Whom Transcatheter Arterial Chemoembolization Was Ineffective or Unsuitable

Abstract

3D-CRT was associated with a 54.3% objective response rate for primary tumors and a 39.0% objective response rate for PVT. Both primary tumor and PVT responses were found to be prognostic factors for overall survival. The present results suggest 3D-CRT is a practical treatment option in HCC patients for whom TACE is ineffective or unsuitable.